Rejection, Transplant Completed Phase 2 Trials for Cyclosporine (DB00091)

Also known as: Graft Rejection / Transplant rejections / Transplant Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00035555Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted KidneyPrevention